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Abstract
Background: Infections with helminths cause an enormous disease burden in billions of animals and plants worldwide.
Large scale use of anthelmintics has driven the evolution of resistance in a number of species that infect livestock and
companion animals, and there are growing concerns regarding the reduced efficacy in some human-infective helminths.
Understanding the mechanisms by which resistance evolves is the focus of increasing interest; robust genetic analysis of
helminths is challenging, and although many candidate genes have been proposed, the genetic basis of
resistance remains poorly resolved.
Results: Here, we present a genome-wide analysis of two genetic crosses between ivermectin resistant and
sensitive isolates of the parasitic nematode Haemonchus contortus, an economically important gastrointestinal parasite
of small ruminants and a model for anthelmintic research. Whole genome sequencing of parental populations, and key
stages throughout the crosses, identified extensive genomic diversity that differentiates populations, but after
backcrossing and selection, a single genomic quantitative trait locus (QTL) localised on chromosome V was
revealed to be associated with ivermectin resistance. This QTL was common between the two geographically
and genetically divergent resistant populations and did not include any leading candidate genes, suggestive
of a previously uncharacterised mechanism and/or driver of resistance. Despite limited resolution due to low
recombination in this region, population genetic analyses and novel evolutionary models supported strong
selection at this QTL, driven by at least partial dominance of the resistant allele, and that large resistance-associated
haplotype blocks were enriched in response to selection.
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Conclusions: We have described the genetic architecture and mode of ivermectin selection, revealing a major
genomic locus associated with ivermectin resistance, the most conclusive evidence to date in any parasitic nematode.
This study highlights a novel genome-wide approach to the analysis of a genetic cross in non-model organisms with
extreme genetic diversity, and the importance of a high-quality reference genome in interpreting the signals of
selection so identified.
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Background
Parasitic worms, commonly termed helminths, are ex-
tremely diverse and frequently responsible for significant
morbidity and mortality in their hosts. Control of hel-
minths of human and veterinary importance is heavily
dependent on the large-scale administration of anthel-
mintic drugs; for instance, the macrocyclic lactone iver-
mectin has been extremely successful in the control of a
number of helminths in both humans and animals [1].
These successes are now threatened by the emergence of
drug resistance. In many species of parasitic nematodes
of livestock, anthelmintic drug resistance is already a
major problem for global agricultural production and
animal welfare and the rapid acquisition of resistance to
both single and multiple drug classes has been widely
documented [2, 3]. Furthermore, there are growing con-
cerns regarding the reduced efficacy of compounds used
in mass drug administration (MDA) programs for some
human-infective helminths, which may reflect the emer-
gence of resistance [4–7]. In spite of the importance of
this issue, remarkably little is known regarding the mo-
lecular mechanisms of resistance to most anthelmintic
drug groups, with the notable exception of the benz-
imidazole class. This is, at least in part, due to a lack of
genomic resources, tools and techniques with which to
study these experimentally challenging organisms.
Haemonchus contortus is a gastrointestinal parasite of
wild and domesticated ruminants that has a major im-
pact on the health and economic productivity of sheep
and goats globally. Resistance of H. contortus to almost
all of the classes of anthelmintic drugs, including to
multiple classes simultaneously, has been documented in
many regions of the world [8–12], and can arise within a
just a few years of introduction of a new drug class
[13, 14]. Partly for these reasons, H. contortus has
emerged as a model parasitic nematode to characterise
anthelmintic resistance, as well as drug and vaccine dis-
covery research as alternate means of control [15–17]. Its
utility as a model is largely due to a greater amenability to
experimentation than most parasitic nematodes; it is
possible to establish and maintain isolates in vivo in the
natural host, perform genetic crosses in vivo, and under-
take in vitro culture for part of its life cycle, allowing drug
assays and genetic manipulation such as RNAi to be
performed [18]. The ability to utilise these molecular ap-
proaches is complemented by extensive information about
the structure of the genome and transcriptional differ-
ences between the major life stages [19–21].
Research into the genetic basis of ivermectin resistance
has been dominated by the examination of a number of
candidate genes [22]. Chosen based on their potential roles
in the mechanism of action or efflux of drugs, many candi-
date genes have been proposed to be associated with iver-
mectin resistance in H. contortus (and other parasitic
nematodes targeted with ivermectin) on the basis of studies
comparing SNP or haplotype frequencies between small
numbers of resistant and susceptible isolates [23–27], or
pre- and post- ivermectin treatment [28, 29]. However,
considering the extremely high levels of genetic diversity of
H. contortus populations, together with the limited number
of well-characterised ivermectin resistant isolates, at best
only circumstantial and inconsistent support is available for
the involvement of any of the leading candidate genes. Fur-
ther, careful validation of a number of these candidates in
different field populations [30] or in controlled crosses [31]
has failed to support previously defined associations be-
tween tested candidates and their associated resistance pro-
file. The lack of consistency between studies had led to
much discussion and debate regarding the complexity of
the genetic basis of ivermectin resistance, both in terms of
the number of loci involved and the extent of genetic
variation between geographically distinct resistant iso-
lates [22, 32, 33]. Moreover, the discordance among
studies broadly reflects the difficulty in identifying real
associations between genotype and phenotype simply
by comparing resistant and susceptible populations, or
individuals, due to the confounding effects of extremely
high levels of genome-wide genetic variation [34].
Genome-wide and genetic mapping approaches are
emerging for H. contortus due to progress in genetic
crossing methodologies [21, 35–40] and an increasing
complement of genomic resources [19–21]. Two serial
backcrosses have previously been undertaken between the
susceptible isolate MHco3(ISE) and two geographically in-
dependent ivermectin resistant isolates, MHco4(WRS)
and MHco10(CAVR) [39] (Fig. 1a,b). Co-segregation of a
single microsatellite marker, Hcms8a20, confirmed that
these backcrosses had successfully introgressed ivermectin
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resistance loci from the two resistant populations into
the susceptible MHco3(ISE) genomic background. Sub-
sequent genetic studies showed that none of the leading
candidate genes from the literature - Hco-avr-14, Hco-
glc-5, Hco-lgc-37, Hco-pgp-9, Hco-pgp-2 and Hco-dyf-7 -
showed evidence of introgression [31], and therefore,
the genetic mediator(s) of resistance remain unresolved.
However, the increasing accessibility to high throughput
sequencing of non-model organisms, together with a
high-quality reference genome for H. contortus, offers an
opportunity to characterise precisely the genome-wide
evidence of introgression and genetic architecture in this
parasite.
Here we build upon these two previous genetic crosses,
extending them for further generations of passage with
ivermectin selection (Fig. 1c), and generating whole genome
sequencing data throughout the experiment. We used a
bulk segregant approach, together with a recently improved
chromosome-scale genome assembly, to characterise the
genetic architecture in the two genetically and geographic-
ally distinct ivermectin resistance populations of H. contor-
tus. In a bulk segregant analysis, allele frequency differences
are determined genome-wide between pools of individuals
that differ in a defined phenotype. This approach has re-
cently been used to map resistance-associated genes in a
number of field and laboratory crosses of parasites [41–43],
including to map variation associated with ivermectin effi-
cacy in three different helminth species [5, 44, 45]. We ana-
lyse these data with traditional population genetic and
novel statistical methods to identify and characterise a
Fig. 1 Outline of the initial crosses, backcrosses, in vivo passage and selection experiments. a. Ivermectin resistant populations MHco10(CAVR) or
MHco4(WRS) (“resistant” haplotypes are depicted as red lines) were crossed with an ivermectin sensitive population MHco3(ISE) (“susceptible”
haplotypes as blue lines) to generate heterozygous F1 progeny. F1 eggs were cultured in vitro to L3, before maturation in vivo to L4/immature
adults, from which females were used to initiate the backcross. b. The first round of backcross was performed by crossing heterozygous females
from the initial cross with susceptible MHco3(ISE) males in vivo, resulting in F2 progeny with reduced heterozygosity due to enrichment of MHco3(ISE)
haplotypes. Resistance alleles were maintained in the backcross population by selection with ivermectin, before seeding the next round of the
backcross with cross-derived heterozygous females and new susceptible MHco3(ISE) males. This process was repeated for four rounds of backcrossing,
resulting in the backcrossed population becoming genetically similar to the MHco3(ISE) parental line in all regions of the genome not linked to
ivermectin resistance. After four rounds of backcrossing, introgressed L3 progeny were used to infect a new recipient sheep, resulting in segregation of
susceptible and resistant alleles in both haplotypes among the progeny (mixed red/blue haplotypes). Eggs were cultured to L3 before infecting two
sheep, one exposed to ivermectin and one that did not receive drug. Post ivermectin treatment, L4/immature adults from both sheep were recovered
on necropsy for sequencing. c. Post-backcross L3 were further passaged into a worm-naive sheep and treated with ivermectin, after which eggs were
recovered and cultured to infective L3 for reinfection. This process was repeated for four generations of passage with selection (but
without backcrossing). L4/immature adults were recovered after passage three and four for sequence analysis
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single genomic introgression region and major QTL as-
sociated with resistance. This work represents the most
comprehensive analysis of the genome-wide impact of
selection and genetics of anthelmintic resistance in a
parasitic nematode to date. Further, the study demon-
strates the power of using a genetic crossing approach,
enhanced by the use of a highly contiguous genome
assembly as a framework for genome-wide analyses, to
eliminate false positive genetic signals in candidate
genes previously associated with resistance.
Results
Extensive genetic diversity defines the parental
Haemonchus contortus populations
Whole genome sequencing of two ivermectin resistant
isolates (MHco10[CAVR] and MHco4[WRS]) and one
susceptible isolate (MHco3[ISE]) (Fig. 2b) revealed high
levels of nucleotide diversity throughout the five autosomes
of the genome (Fig. 2a), with the average diversity almost
twice as high in the resistant isolates (MHco10[CAVR]
mean π = 0.035 ± 0.008 standard deviations (SD);
MHco4[WRS] mean π = 0.038 ± 0.008 SD) than the sus-
ceptible one (MHco3[ISE] mean π = 0.022 ± 0.008 SD)
(Fig. 2c; Additional file 1: Figure S1A). The two X chromo-
somal scaffolds were significantly less diverse (MHco3[ISE]
mean π = 0.008 ± 0.008, MHco10[CAVR] mean π = 0.014
± 0.012, MHco4[WRS] mean π = 0.017 ± 0.014) (Fig. 2c;
Additional file 1: Figure S1A), consistent with our recent
finding that the X chromosome contains as little as 10% as
much genetic diversity relative to the autosomes [21]. Each
parental population contained local regions of high
diversity that differentiated it from the others; of the
~ 7.6 million biallelic SNPs distributed in the genomes
of the samples analysed, ~ 514 thousand were private
to MHco3(ISE) (Additional file 2: Figure S2A), ~ 960
thousand to MHco10(CAVR) (Additional file 2: Figure S2B)
and ~ 685 thousand to MHco4(WRS) (Additional file 2:
Figure S2C). In addition, high quality homozygous
structural variants were evident between populations
(Additional file 3: Figure S3A,C,E), with a large number
of deletions, and substantially fewer duplications and
inversions detected (Additional file 3: Figure S3B,D,F).
Further, we examined short-range haplotype diversity in
each population by measuring linkage disequilibrium
(LD) between pairs of SNPs detected in paired reads
(Additional file 1: Figure S1B). Although restricted by the
Pool-seq design to pairwise SNP comparisons less than
500 bp apart, i.e., within a read pair, we nevertheless
observed considerable decay in LD over this distance.
Moreover, the rate of LD decay was correlated with
nucleotide diversity: a greater loss of LD in the
MHco4(WRS) and MHco10(CAVR) populations over the
500 bp was observed, relative to the less diverse, susceptible
MHco3(ISE) population.
Genetic diversity between each of the three parental
populations was assessed by pairwise analysis (measured
by FST of single nucleotide polymorphisms [SNPs] in 10
kbp windows), which confirmed significant genome-wide
differentiation (Fig. 2d). This is highlighted by multiple
discrete peaks of differentiation within each chromosome,
both between resistant and susceptible stains, but also be-
tween the two resistant populations. We must therefore
conclude that most of this genetic differentiation reflects
underlying genetic structure between populations unre-
lated to their drug resistance phenotype; this is perhaps
not surprising, given they are derived from reproductively
isolated populations due to their geographic distribution
(Fig. 2b). In addition, MHco3(ISE) was subject to multiple
rounds of inbreeding during is original derivation as a la-
boratory population [46], whereas the resistant popula-
tions have not been subjected to deliberate inbreeding and
were isolated from outbred populations more recently.
Collectively, these data emphasise the challenge of charac-
terising genetic variation associated with phenotypes such
as drug resistance by simply comparing genetic diversity
between a susceptible and resistant population without
accounting for the extensive background genetic variation
present.
Genome-wide analysis of genetic diversity reveals the same
single large introgressed region in both backcross lines
To map genetic variation linked to ivermectin resistance in
the two parental resistance populations, we sequenced pre-
and post ivermectin treatment samples of the initial back-
cross between each of MHco10(CAVR) and MHco4(WRS)
populations with the MHco3(ISE) susceptible genetic back-
ground [39], as well as after subsequent passage of the
introgressed populations with further treatment. Consistent
with the backcross design, pairwise comparisons were
made between specific stages of the experiment and the
MHco3(ISE) susceptible parent. We hypothesised that
where backcross populations were not subjected to further
ivermectin treatment (Fig. 1: MHco3/10.BC4.noIVM &
MHco3/4.BC4.noIVM), there would be relatively little gen-
etic differentiation throughout the majority of the genome
between the defined population and MHco3(ISE). By con-
trast, where populations were subjected to further ivermec-
tin treatment, we hypothesised that genetic differentiation
with MHco3(ISE) should increase close to any resistant
allele, with high levels of differentiation in regions of the
genome linked to an ivermectin resistance-conferring locus
and low levels of differentiation elsewhere.
As hypothesised, little genetic differentiation between the
post-backcross, no-selection population and the susceptible
parental population was observed in either cross (Fig. 3;
MHco3/10.BC4.noIVM and MHco3/4.BC4.noIVM). After
backcrossing, in the absence of selection, genetic material
from the susceptible parent should comprise approximately
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97% of the population due to the repeated backcrossing
with MHco3(ISE) (resistant alleles comprise half of the ini-
tial cross population and reduce by a half with each back-
cross), making them largely indistinguishable from the
susceptible parent. Selection increases the fraction of alleles
derived from the resistant parent, but is limited by the
backcross design; no more than 50% of the genetic material
at any location may originate from the resistant parent.
Upon further selection (Fig. 3; MHco3/10.BC4.IVM and
MHco3/4.BC4.IVM), a region of differentiation from the
susceptible parent, particularly in the MHco3/10 cross, was
localised to the right arm of chromosome V. This region
was markedly differentiated in both MHco3/10 and
MHco3/4 crosses after in vivo selection and passage (Fig. 3;
MHco3/10.BC4.IVM.P3, MHco3/4.BC4.IVM.P3, MHc3/
10.BC4.IVM.P4 and MHc3/10.BC4.IVM.P4). No other re-
gion of the genome displayed a marked and progressive in-
crease in differentiation throughout the crosses. To test this
Fig. 2 Genetic diversity within and between parental populations used in the genetic cross. a. The 279 Mbp V3 genome assembly of H. contortus
consists of five autosomal and two X chromosome scaffolds, named based on synteny with Caenorhabditis elegans chromosomes. The size of
each scaffold is indicated, and are presented in order by length (Mbp). b. Geographic origin of the susceptible MHco3(ISE) and ivermectin
resistant MHco10(CAVR) and MHco4(WRS) populations used in the genetic crosses. All populations are archived at the Moredun Research
Institute, UK – while MHco3(ISE) has been maintained there for decades, it was originally isolated in East Africa. c. Within-population nucleotide
diversity for each of the parental populations, calculated as mean diversity per 100 kbp windows throughout the genome using npstat. d.
Between population diversity, calculated as pairwise FST in 10 kbp windows throughout the genome using popoolation2. Colours here and
throughout represent the chromosomal scaffolds as described in A
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explicitly, we determined the correlation between change in
FST per each genomic window and progression through the
cross; only the chromosome V region demonstrated pro-
gressive genetic differentiation over time (Additional file 4:
Figure S4A,B), which was highly correlated between the
two crosses (Additional file 4: Figure S4C).
Collectively, these data suggest that there is a single
introgression region on chromosome V representing a
major QTL that is under selection upon drug exposure,
and that this region is under selection in the two inde-
pendent serial backcrosses performed. This conclusion
was supported by an independent evolutionary analysis,
which compared the observed frequencies of variants
associated with the resistant parental population with
the distribution of allele frequencies expected under the
assumption of selective neutrality (Additional file 5:
Figure S6). An over-representation of alleles (71 and
91% of the total number of such alleles for the MHco3/10
(Additional file 5: Figure S6A) and MHco3/4 (Additional
file 5: Figure S6B) crosses, respectively) with atypical fre-
quencies towards the right hand end of chromosome V
were strongly inconsistent with the neutral expectation,
suggesting that they had increased in frequency under the
influence of linked selection (Fig. 3b).
Characterisation of the introgression region located on
chromosome V
A comparison of genetic diversity on chromosome V be-
tween MHco3(ISE) and the end-point of both crosses
(BC4.IVM.P4) revealed a strikingly similar pattern be-
tween the crosses, with a major region of differentiation
spanning 37–42 Mbp, and a second but lesser increase
in genetic differentiation between 45 and 48 Mbp that is
most prominent in the MHco3/10 population (Fig. 4a).
Encouragingly, the Hcms8a20 microsatellite marker (lo-
cated at position 36.16 Mbp along chromosome V) that
was shown to be genetically linked to ivermectin resist-
ance in the preliminary analysis of these backcrosses
[39] lies adjacent to the QTL region, suggesting that
while it is strongly linked to resistance, it is unlikely to
be completely linked with a locus directly causing this
phenotype. The FST data are supported by a comparison
of Tajima’s D throughout this region (Fig. 4b; top plots).
Although variation in Tajima’s D was observed throughout
Fig. 3 Genome-wide analysis of ivermectin associated loci. a. Pairwise genetic diversity throughout the MHco3/10 (left plots) and MHco3/4 (right
plots) backcrosses. In both crosses and at each point in the backcross, the experimental population was backcrossed against the MHco3(ISE)
parental population – the data are therefore presented to compare the genetic diversity (FST measure in 10 kbp windows using popoolation2)
between MHco3(ISE) and each sampled time point in the cross as per the cross scheme in Fig. 1. b. Output of the single-locus evolutionary
model, describing sites which were inconsistent with a model of neutral evolution, measured using a likelihood threshold. Note that the X
chromosome is not represented. Colours represent the chromosomal scaffolds as described in Fig. 2a
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the genome in both crosses (Additional file 6: Figure S7),
the greatest variation between the susceptible parent and
backcrossed lines was observed at approximately 39–40
Mbp (Fig. 4b; bottom plots), which was associated with
significantly negative Tajima’s D in the backcrossed lines
consistent with strong positive selection. In contrast to
Fig. 4 Analysis of chromosome V and the major region of introgression. a. Genetic differentiation (FST) measured in 10 kbp windows throughout
chromosome V is presented between MHco3(ISE) parent and both MHco3/10.BC4.IVM.P4 (light) and MHco3/4.BC4.IVM.P4 (dark) representing the
final time point of the crosses. Inset presents the smoothed FST distribution of the two comparisons. Published candidate genes in or near the
introgression region (grey vertical lines), as well as the original Hcms8a20 microsatellite marker that Redman et al. (2012) linked to ivermectin
resistance (black vertical line), are presented. b. Comparison of Tajima’s D per chromosome between MHco3(ISE) parent (blue), MHco10(CAVR)
(left panels) or MHco4(WRS) (right panels) and passage 3 (MHco3/10.BC4.IVM.P3 or MHco3/4.BC4.IVM.P3; orange) and passage 4 (MHco3/
10.BC4.IVM.P4 or MHco3/4.BC4.IVM.P4; yellow) of the crosses (top panels). Tajima’s D was calculated using npstat in 100 kbp windows spanning the
genome. To emphasise the difference between the susceptible MHco3(ISE) and resistant passages 3 and 4 samples, we calculated the variance in
the mean value of Tajima’s D between samples, which is presented as red smoothed line (bottom panel). The null expectation is that variance
between these samples will be low in regions of the genome not under selection. c. Inferred likelihoods from the multi-locus population genetic
model. The mean likelihood of the best fitting single-locus model at each locus position is shown by the solid black line; the light blue interval
around this line shows the 5–95% confidence interval for this statistic calculated by a bootstrapping process. The position of the maximum
likelihood value is shown by the vertical black dotted line; a confidence interval for this position, calculated from the bootstrapping values, is
shaded in grey. The mean likelihood of the best fitting constrained two-locus model is shown by the black dashed line; the value shown
represents the best value of the model given that one of the selected loci is at the given position
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the FST data, analysis using Tajima’s D suggested a single
peak, corresponding to a single site or region under posi-
tive selection.
A total of 74,424 variants (4.71% of the total variants
found on chromosome V) were found to be segregating
within the 37–42 Mbp region, of which 14,009 and 12,827
variants presented a signal of differentiation (greater than
five standard deviations from the genome-wide mean P
value from the Fisher’s exact test) between the susceptible
and CAVR and WRS lines, respectively, due to variable
degrees of linked selection with the causative allele. As the
genome assembly used in this study was not annotated, it
was difficult to prioritise this variant list further in the
context of their impact on coding sequences. However,
many candidate genes have been proposed in the litera-
ture as being in association with ivermectin resistance; to
determine their possible role in driving resistance here, we
curated a list of genes that have been explored in H. con-
tortus, and/or had been shown to confer ivermectin resist-
ance when mutated in C. elegans. We determined the
location of these genes in the current assembly, either via
mapping the published gene models from the V1 annota-
tion, or determining the closest H. contortus orthologous
gene from C. elegans candidates using Wormbase Para-
site [47] (Additional file 7: Table S2; Additional file 8:
Figure S9). At least one candidate gene was located in
each chromosome; in chromosome V, the location of
six candidate genes were determined. However, none of
these genes were found in the main introgression re-
gion defined by the FST analysis (Fig. 4a; vertical anno-
tated lines). Three genes – Hco-lgc-55, Hco-avr-15, and
Hco-pgp-1(9), the latter two of which have a strong
association with ivermectin resistance – lie to the
telomere-side of the introgression region, however, they
are located on the periphery of the FST peaks rather
than within them, suggesting that they are unlikely
candidates to be under direct selection. Considering the
absence of candidate resistance genes in the FST peaks,
we conclude that the driver(s) of ivermectin resistance
in the MHco4(CAVR) and MHco4(WRS) populations
are novel and have not been previously described in
association with ivermectin resistance.
A multi-locus population genetic model provided clar-
ity on the extent to which the location of the selected
allele could be determined by our data. In contrast to
FST and Tajima’s D, this model explicitly considered link-
age between variant alleles arising from their common
parental origin. Putative segregating sites in chromo-
some V between the resistant and susceptible parental
populations were identified: A total of 474 such sites
were identified in the MHco3/10 dataset, with 157 sites
in the MHco3/4 dataset. Calculations were then per-
formed upon data from these loci. The maximum likeli-
hood of the allele under selection was in a broadly
consistent location in each experiment, being inferred to
exist at 40.10 and 41.31 Mbp respectively. However,
there was considerable uncertainty in this location; a
conservative estimate gave confidence intervals of 36.86
to 44.03 Mbp and 37.41 to 47.56 Mbp in each case
(Fig. 4c). These broad confidence intervals were ex-
plained by the population structures inferred by the
model, which explicitly considered the location of
crossover recombination events between the parental
haplotypes throughout the experiment. Example structures
generated using the maximum likelihood parameters for
each population show how selection for resistance drives
the accumulation of genetic material from the resistant par-
ent through the course of the experiment (Fig. 5); these
outputs may be contrasted with equivalent data generated
under a model of selective neutrality (Additional file 9:
Figure S10). Across 250 replicates, a mean of 177.1 cross-
over recombination events were predicted in chromosome
V of the final MHco3/10 population (range 120 to 224),
giving a mean length of a block of parental genome of
17.64 Mbp; in the final MHco3/4 population a mean of
186.4 recombination events were seen (range 143 to 238),
giving a mean parental haplotype block length of 17.06
Mbp. Under selection, blocks of genome containing the
selected allele are favoured; the large size of each block
reduces the precision with which the location of the allele
under selection can be identified.
An extended multi-locus model incorporating selec-
tion on alleles at two loci did not find evidence for selec-
tion at more than one allele; despite the second peak of
differentiation found at approximately 45 Mbp in the
FST analysis, evidence for a second site was not identi-
fied. The identification of independent selected alleles
requires them to be separated in the genome by recom-
bination; on the basis of our knowledge of recombin-
ation in this system we searched for alleles located at
least 2 Mbp apart in the genome. Under this constraint,
the best fitting model identified variants under selection
at the positions 38.6 Mbp and 45.7 Mbp in the MHco3/
10 data (Additional file 10: Figure S8A), and at the posi-
tions 41.2 Mbp and 44.8 Mbp in the MHco3/4 data
(Additional file 10: Figure S8B). However, these models fit
the data less well than the single-driver model described
above (Fig. 4c), favouring an explanation in which only one
variant is under selection. We note that the single-driver
model is as a special case of the two-driver model, for
which both drivers are in precisely the same location and
the selective effect of one of the drivers is set to zero; re-
moving the constraint that the alleles be separated would
result in a fit to data at least as good as the single-driver
model. In conclusion, this analysis cannot exclude the pres-
ence of more than one drug-resistance variant in the identi-
fied region of chromosome V, but provides no evidence to
support the existence of a second selected allele.
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Strength of selection
We further used the multi-locus single driver model to
infer the strength and manner of selection in favour of
the drug resistance allele. Data in each case indicated
strong selection for the resistant allele (Fig. 6), such that
susceptible worms produce multiple times fewer off-
spring than the resistant worms under drug treatment.
In each case the value of the dominance coefficient, h,
was less than one, indicating either an additive effect for
the MHco10(CAVR) case, whereby each copy of the
Fig. 5 Haplotype structure of chromosome V in an example output from the multi-locus model. Segments of genome from the parent
containing the resistance allele are shown in red, while segments of genome from the susceptible parent are shown in blue. Data shown were
generated using the maximum likelihood parameters in each case
Fig. 6 Likelihood surface describing inferred selection parameters for the resistance allele. Within our model, the fitness of a genotype is
determined by the alleles at a single resistant allele, with homozygous susceptible worms having fitness 1, homozygous resistant worms having
fitness 1 + s, and heterozygous worms having fitness 1 + hs in the presence of the drug. In each plot, calculated for both the parental (a)
MHco10(CAVR) and (b) MHco4(WRS) populations, we identify the location of the maximum likelihood values for selection (s) and dominance
coefficients (h) (black dot), and the likelihood landscape surrounding this maximum value (log likelihood heatmap scale: yellow = high likelihood;
blue = low likelihood) for the position in the genome of the resistant allele. Changes of the order of 100 likelihood units indicate substantial
differences in the extent to which the model fits to the data
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resistance allele contributes an equal amount of resist-
ance, or weak dominance for the MHco4(WRS) data,
whereby the first resistance allele contributes slightly
more than the second. This is consistent with the pheno-
typic characterisation of the initial crosses, whereby the F1
individuals that would have been heterozygous for resist-
ant alleles were partially resistant to ivermectin [39]. As
such, having two copies of the resistant allele had a greater
phenotypic effect than one; these data therefore have im-
plications for the mechanism of the drug resistance allele,
and evolution of drug resistance in general terms, as dis-
cussed further below.
Discussion
Genetic mapping identifies a major ivermectin resistance
QTL in two independent H. contortus populations from
different continents
We have analysed whole genome sequence data collected
from the most recent phase of a multi-generational cross-
ing experiment conducted in populations of the parasitic
worm H. contortus. Our analysis unequivocally identi-
fied a single region of introgression within chromo-
some V that contains at least one major ivermectin
resistance allele. This major ivermectin resistance
QTL is common to two independent ivermectin resistant
populations – MHco10(CAVR) and MHco4(WRS) – that
were originally isolated from Australia and Africa, respect-
ively. This genomic region was clearly distinguished in the
experimental data using different population genetic
methods. Although this region in which we infer a
selected allele to exist is relatively large (Conserva-
tively ~ 5 Mbp from 37 to 42 Mbp, comprising 1.73%
of the genome), each of our analytical approaches
consistently identified the same region under selection,
with no other comparable regions of introgression else-
where in the genome in either of the two backcross exper-
iments. The annotation of the H. contortus genome is
ongoing, and hence we can only make a best guess
estimate of the number of putative genes in this region:
we predict approximately 20,000 genes in the 279 Mbp
genome, which would correspond to almost 360 genes in
the introgression region (~ 72 genes/Mbp). Considering
the high diversity between parental populations, and lim-
ited recombination in this window, it is difficult to reduce
this number of genes further. However, our data suggests
this introgression region is the most important ivermectin
resistance QTL in the MHco10(CAVR) and MHco4(WRS)
populations.
There has been much discussion and debate regarding
the complexity of the genetic basis of ivermectin resist-
ance, both in terms of the number of loci involved and
the extent of geographical variation [22, 32, 33]. Our re-
sults, however, strongly suggest a single locus (or poten-
tially multiple closely linked loci) is likely to be the
major effector of ivermectin resistance in these two pop-
ulations. We acknowledge that we cannot discount pre-
viously described candidate genes as mediators of
resistance in other populations of H. contortus, or in other
nematode species. Moreover, our data does not exclude a
driver of transcriptional regulation within the introgression
region that is under selection, which itself influences ex-
pression of other genes, including candidate genes, outside
of the introgression region. However, most of the leading
published candidate ivermectin resistance genes including
Hco-glc-5, Hco-avr-14, Hco-lgc-37, Hco-pgp-2 and Hco-dyf-7
were not located in or near the QTL, which is consistent
with a recent study using targeted sequencing of these
genes in which none showed a signal of introgression in
these two backcross experiments [31]. This suggests that
none of these candidate genes show evidence of selection
in response to ivermectin treatment in the MHco10(CAVR)
and MHco4(WRS) populations. Although we identified
three other previously described candidate genes –
Hco-lgc-55, Hco-avr-15, and Hco-pgp-1(9) – adjacent to the
introgression region, none were found within the peak of
the region suggesting that these also are unlikely to be
major direct targets of ivermectin-mediated selection. This
is in contrast to a recent genome-wide analysis of
multi-drug resistance of a field population of Teladorsagia
circumcincta, a gastrointestinal nematode of sheep and
goats, in which a copy number variant of Tc-pgp-9 was ex-
panded in an ivermectin resistant isolate. Additionally,
Tc-lgc-55 was identified in a region of high differentiation
between resistant and susceptible individuals [44]. Indeed, a
key conclusion of this earlier work was that ivermectin re-
sistance was likely to be highly multigenic. Given the frag-
mented nature of the T. circumcincta assembly, it is
intriguing to speculate whether many of the signals ob-
served in the earlier study, including one or both of these
genes, are not direct mediators of resistance, but rather
show evidence of selection due to being linked to nearby
driver mutation, as is likely the case in H. contortus shown
here.
What might account for the large number of candidate
genes previously suggested to be associated with iver-
mectin resistance? The answer might lie in our direct
comparison of genome-wide diversity between the par-
ental populations (Fig. 2d). The extent of genetic diver-
gence between these populations is striking, and makes
it easier to understand how particular sequence poly-
morphisms might be naively attributed to being associ-
ated with resistance, when in fact they simply represent
genetic variation that occurs as a result of the independent
evolutionary histories and lack of interbreeding between
the populations. Our results highlight the challenge of
interpreting simple direct comparison of genetically dis-
tinct populations, even with genomic approaches, when
trying to disentangle those genetic polymorphisms
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underlying resistance from a complex background of gen-
etic variation independent from the resistance phenotype
of individuals from a given population. The use of con-
trolled genetic crosses as presented here and elsewhere
[31, 39, 44], whereby population genetic structure can
be explicitly accounted for in the analysis, provides a
powerful way to mitigate the challenge of discriminat-
ing resistance-causing alleles from background genetic
variation.
Population genetic and evolutionary modelling defined
the boundaries of the ivermectin resistance QTL
Previous research has highlighted the value of novel
methods in population genetics for analysing experimen-
tal cross populations [48]. In order to gain the maximum
possible insight into the data collected, we extended pre-
vious statistical work [49, 50] to account for stochasticity
in the experiment. Specifically, the random location of
recombination events, in the context of strong selection,
and genetic drift imposed by population bottlenecks in
the experimental design, leads to potential variation in
the final outcome of the experiment. With prior know-
ledge of the recombination rate [21], we used evolution-
ary simulations reproducing the experimental design to
explore the range of experimental outcomes arising
under multiple scenarios of selection; this allowed for a
direct inference of evolutionary parameters.
Inference of selection from the multi-locus model sug-
gested the presence of stronger selection for the drug re-
sistance allele in the MHco3/10 cross than in the
MHco3/4 cross (Fig. 6). Further, although the data sug-
gests that resistance is at least additive in both crosses,
that is, heterozygotes are likely to confer some resistance
and increased resistance is achieved by having two re-
sistant alleles, there is some evidence for dominance in
the MHco4(WRS) population, whereby the second re-
sistant allele confers a lesser fitness advantage. A previ-
ous study reported resistance to be a dominant trait in
the CAVR population [36] on the basis that no differ-
ence was observed in the resistance levels of heterozy-
gote and homozygote resistance worms. Our finding of
additivity arises from the evolution of the worm popula-
tions during passage following the backcross experiment
(i.e., in BC4.IVM.P3/4 samples versus the BC4.IVM data),
and particularly the fixation of alleles from the resistant
parent at putative segregating sites near the inferred pos-
ition of resistance. In our model, alleles can reach fix-
ation only where there is selection in favour of the
homozygous resistant type over and above that for het-
erozygote resistant individuals.
Our ability to resolve the precise location of the vari-
ant under selection was limited by the number of re-
combination events in the worm population. Precise
identification of the location of an allele under selection
requires that the allele not be linked to other nearby al-
leles in at least some fraction of individuals in the popu-
lation. While the inherent biological recombination rate
here has a role, population bottlenecks in each round of
the cross induced by the use of only a limited number of
individuals – 50-100 male and female worms per cross
generation – reduced our ability to resolve the region of
introgression further toward a single causative gene or
variant. These bottlenecks were due to the limited num-
ber of L4 worms that it was possible to collect from each
sheep and transplant in the successive generation of the
cross. Genetic drift induced by successive population
bottlenecks introduced considerable uncertainty in the
outcome of the experiment, such that replicate sets of
allele frequencies from our model showed considerable
differences between each other (Additional file 11:
Figure S5). This implies that the data from the experi-
ment itself should be understood as the output of a sto-
chastic process; beyond the clear large-scale patterns
observable in the data and detailed above, more minor
details of the output might not be seen again were the
experiment to be repeated. The structure of the experi-
ment thus imposes a limit on our ability to infer the
location of a selected allele; an improved characterisation
of selection would likely best be achieved by conducting
further generations of cross as performed within this ex-
perimental framework to induce more recombination
events, reducing the mean size of parental genomic
blocks. However, such a course of action would be limited
in scope were it not accompanied by the use of larger L4
populations, for example by the simultaneous passage of
the population through multiple animals. Clearly, a larger
or longer experiment would have cost and welfare impli-
cations; the statistical framework we have developed
would help to design and justify such an approach.
We note the importance of linkage between sites in
the analysis of data from genetic cross populations.
Whereas standard metrics such as FST and Tajima’s D do
not explicitly account for linkage between sites, we have
here implemented methods which explicitly account for
the genomic structure arising from the history of the
cross population, including the stochasticity that exists
in that structure due to genetic drift and random recom-
bination. While standard metrics can identify sites of
maximum differentiation in a population with great pre-
cision, neglect of the inherent stochasticity in the out-
come of an experiment can lead to an overconfidence in
the extent to which they provide an accurate diagnosis
of the causative variant of selection.
Importance of chromosome-level genome assemblies for
genetic mapping and population genomics
The success of identifying a single region of introgression
was dependent upon an improved chromosomal-scale
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reference genome assembly for the H. contortus isolate,
MHco3(ISE).N1. This isolate was used in the original
draft assembly of this species [19], which was derived
via inbreeding of the same MHco3(ISE) population
used in the backcrosses presented. Without a contiguous
chromosomal-scale genome assembly, interpretation of
these type of analyses can be extremely challenging; true
genetic signal(s) can be obscured by technical artefacts as-
sociated with a fragmented assembly, such as short contigs
lacking spatial orientation, multiple haplotypes present,
collapsed paralogs, and poor resolution of repeat struc-
tures. As a consequence, both read mapping and variant
calling in fragmented genomes can be suboptimal. These
technical challenges are exacerbated in highly poly-
morphic species such as H. contortus and T. circumcincta
[44], for which reference genomes were constructed from
pools of individuals that, despite efforts to reduce genetic
variation by inbreeding, were highly polymorphic. Perhaps
the biggest problem with using a fragmented genome
assembly for genome-wide analyses is the inability to
determine linkage. Signals of selection will often be dis-
persed across multiple scaffolds of a fragmented draft gen-
ome assembly when in reality they are adjacent to each
other in a single genomic region. This can potentially can
give rise to the erroneous conclusion that multiple signals
of selection are present, when in fact only a single selected
locus exists. We illustrate these selection artefacts by pre-
senting the sequence data we have generated here on
different versions of the MHco3(ISE).N1 reference gen-
ome assembly (Fig. 7). In the fragmented draft genome
assemblies, the signals of genetic differentiation be-
tween susceptible and resistant populations were nu-
merous and dispersed across many assembly scaffolds,
suggesting that many discrete regions of the genome
may be under selection (Fig. 7; top plot). However, only
after significant improvement in chromosome contigu-
ity does the introgression region on chromosome V be-
come evident (Fig. 7; bottom plot). Genome contiguity
(or lack of ) thus will be an increasingly important fac-
tor in the interpretation of analyses exploiting unfin-
ished draft reference genomes of non-model species,
particularly as whole genome sequencing becomes
cheaper and more widely adopted.
The extensive genome-wide diversity between parental
populations re-emphasises that H. contortus is highly
genetically diverse both within and between populations.
It is clear, however, that short read mapping-based ana-
lyses exploiting a single reference genome will underesti-
mate this diversity. In this study, we have used only a
subset of the total variation present, i.e., only single nu-
cleotide polymorphisms, to characterise the introgression;
however, understanding the functional consequences of
population-specific diversity will rely on a more compre-
hensive description of all of the variation that defines a
population. As an alternative to a linear reference genome,
the use of population genome graphs – a non-linear
Fig. 7 Impact of genome contiguity on the resolution of the introgression region. The same pairwise comparison – MHco3(ISE) vs MHco3/
10.BC4.P4 – is presented using three versions of the H. contortus genome; the published V1 draft assembly [19] (top; N50 = 0.083 Mbp, N50(n) =
1151, n = 23,860), an intermediate improved assembly (middle; N50 = 5.2 Mbp, N50(n) = 16, n = 6668), and the chromosomal-scale assembly
presented here and elsewhere [21] (bottom; N50 = 47.4 Mbp, N50(n) = 3, n = 8). The top and middle plots are coloured light and dark grey to
reflect alternate contigs/scaffolds, whereas the bottom plot is coloured as in Fig. 2a
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or branching reference that contains alternate paths
representing known genetic variation – may be more suit-
able [51], and allow better characterisation of known vari-
ation that is too complex to be analysed using a linear
reference [52]. This may be possible once a comprehensive
analysis of population and perhaps global genetic diversity
is made available [53]. Alternatively, de novo reference
sequences from geographically diverse isolates may be re-
quired, ideally sequenced and assembled using long-read
sequencing technology, to allow a more comprehensive
description of genetic variation within a population while
allowing large scale variation between reference populations
to be characterised.
Conclusion
Our genome-wide analysis of two genetic crosses be-
tween ivermectin resistant and ivermectin sensitive iso-
lates has identified a major ivermectin resistance QTL
shared between two genetically and geographically dis-
tinct populations of Haemonchus contortus. Traditional
population genetic analyses highlighted the extensive
genetic variation both between and within the parental
populations used to construct the cross, potentially
explaining why candidate genes identified using ap-
proaches that did not control for this genetic diversity
have not been validated, and by using novel population
genetic methods, we could better account for the cross-
ing procedure and its impact on the outcome of the ex-
periment. This work represents the most comprehensive
analysis of the genetics of anthelmintic resistance in a
parasitic nematode to date, and demonstrates the power
of genetic crossing and a contiguous genome assembly
to eliminate false positive genetic signals typically linked
to resistance. Importantly, these data show that many of
the previously proposed candidate genes are not in-
volved in ivermectin resistance in these isolates, and
should focus future efforts on identifying the causal vari-
ant within the QTL we identify.
Methods
Background of H. contortus populations and the original
backcross
The MHco3(ISE), MHco4(WRS) and MHco10(CAVR)
are H. contortus populations maintained and stored at
the Moredun Institute. MHco3(ISE) was originally derived
by multiple rounds of inbreeding of the SE population [46].
The precise provenance of SE is not clearly recorded
but is thought to be originally obtained from East Africa.
MHco10(CAVR) is derived from the Chiswick Avermectin
Resistant (CAVR) strain, an ivermectin resistant field popu-
lation originally isolated in Australia [54]. MHco4(WRS) is
derived from the ivermectin resistant White River Strain
(WRS) originally isolated from South Africa [14].
The experiment described here extends two previously-
described backcross experiments. The construction,
phenotypic validation, and initial microsatellite analysis of
these backcrosses has been described previously [39], and
is outlined in Fig. 1a and b. Briefly, two independent
crosses were performed in parallel: (i) MHco3(ISE) x
MHco10(CAVR), and (ii) MHco3(ISE) x MHco4(WRS).
In the first generation of each cross, female worms of the
ivermectin resistant parental populations [MHco10(-
CAVR) or MHco4(WRS)] were crossed with male
MHco3(ISE) worms, to generate lines designated MHco3/
4 and MHco3/10, respectively (Fig. 1a). After the first
cross, the F1 generation females were mated to male
MHco3(ISE), resulting in backcross generations desig-
nated MHco3/10.BCn and MHco3/4.BCn, where n is the
number of backcross generations (BC). This involved the
recovery of immature worms from the abomasum at day
14 post infection by necropsy of donor sheep; worms were
washed in physiological saline (0.85% NaCl) after which
their sex was determined [55], followed by surgical trans-
fer of 45–100 male MHco3(ISE) and 50–100 female F1
L4/immature adult worms into worm-free recipient lambs
all within 2 h of the original collection. This process of
backcrossing was repeated for a total of 4 generations, i.e.,
MHco3/10.BC4 and MHco3/4.BC4 (Fig. 1b). In vivo iver-
mectin selection was applied after mating and before
collection of eggs to enrich for ivermectin resistant adults
to be used in the subsequent round of the backcross. A
controlled efficacy test was performed on the three par-
ental-, MHco3/4.BC4, and MHco3/10.BC4 populations
to determine the initial levels of ivermectin efficacy,
and the degree of resistance acquired in the intro-
gressed lines. After four rounds of backcrossing, a se-
lection experiment was performed. MHco3/10.BC4 and
MHco3/4.BC4 populations were used to infect recipient
sheep, after which eggs were collected and in vitro culture
to L3. These infective larvae were used to infect two sheep
per population, one that received 0.1 mg/kg ivermectin
and one that remained drug naive. At 7 days post treat-
ment, treated and naive L4/immature adults were recov-
ered by necropsy and stored for molecular analysis.
The backcrosses described above were extended by
performing a further four rounds of in vivo ivermectin
selection, during which mating within the BC4 popula-
tion continued (Fig. 1c). For each cross, progeny of the
BC4 generation were cultured to L3 and used to infect a
donor sheep, which was subsequently treated with iver-
mectin (0.1 mg/kg in round 1, followed by 0.2 mg/kg in
following rounds). Eggs from ivermectin-treated survivor
adults were collected post-treatment, cultured to L3, and
used to infect a new donor sheep. L4/immature adults
were collected by necropsy after rounds three (i.e.,
BC4.IVM.P3) and four (i.e., BC4.IVM.P4) of selection and
stored for molecular analysis.
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The sheep used in this study were born and raised in-
doors at the Moredun Research Institute under worm
free conditions. For those recipient sheep requiring sur-
gery: anaesthesia was induced either by intravenous thio-
pentone injection, or using a halothane and oxygen
mask. The sheep were then intubated and anaesthesia
maintained using halothane and oxygen. Sheep were
routinely injected with a non steriodal anti-inflammatory
agent (1 mg/kg meloxicam; Metacam 20mg/ml solution
for injection; Boehringer Ingelheim) and antibiotic (7
mg/kg amoxicillin/1.75 mg/kg clavulanic acid, Synulox
ready-to-use injection; Pfizer) and closely monitored on
completion of the surgery. No adverse effects were
noted. Sheep were humanely killed under schedule 1 to
the Animals (Scientific Procedures) Act.
Library preparation and sequencing
Whole genome sequencing was performed on the three
parental populations (MHco3[ISE], MHco10[CAVR] &
MHco4[WRS]), and from each cross, pre and post iver-
mectin treatment following four rounds of backcrossing
(MHco3/10.BC4.noIVM, MHco3/4.BC4.noIVM, MHco3/
10.BC4.IVM, MHco3/4.BC4.IVM), and after 3 and 4
rounds of additional selection after the backcross
(MHco3/10.BC4.IVM.P3, MHco3/4.BC4.IVM.P3, MHco3/
10.BC4.IVM.P4, MHco3/4.BC4.IVM.P4). Pools of male and
female worms were included for the parental (n = 50–60
worms) and BC4 samples (n = 25–30 worms), whereas
only female worms were used in the passage 3 & 4 sam-
ples (n = 60 worms). Genomic DNA from each pooled
sample was prepared using a phenol chloroform extrac-
tion protocol as previously described. Sequencing libraries
were prepared using a PCR-free protocol [56], and se-
quenced as described in Additional file 12: Table S1. We
generated approximately 6.14 × 1011 bp of sequence data,
which equates to approximately 199.65× unmapped
genome coverage per sample. Raw sequence data quality
was analysed using FASTQC (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc/) and was assessed using
MultiQC [57] prior to further processing.
Mapping and variant analysis
Raw sequence data was mapped per lane to the version
3 reference genome (available here: ftp://ngs.sanger.ac.
uk/production/pathogens/Haemonchus_contortus) using
BWA-MEM [58](default parameters with -k 15). Samples
for which multiple lanes of mapped data were available were
merged, duplicate reads were marked and removed using
Picard v2.5.0 (https://github.com/broadinstitute/picard),
and mapped perfect read pairs were extracted per
sample (samtools-1.3 view -f 2).
Genome-wide variants were determined for each sample
using samtools-1.3 mpileup (−F 0.25 -d 500). Nucleotide
diversity and Tajima’s D was determined using npstat [59],
which required pileup files (which we derived from the
mpileup generated above) that were split per sample per
chromosome as input. We determined short-range linkage
disequilibrium between pairs of variants in single and
paired reads using LDx [60]. We compared these data with
estimates of LD decay over genetic distance as proposed by
Hill and Weir [60, 61]. Popoolation2 [62] was used for the
analysis of pairwise genetic diversity throughout the gen-
ome. Briefly, the mpileup file was converted into a synchro-
nised file (popoolation2 mpileup2sync.jar --min-qual 20),
after which indels + 5 bp (popoolation2 identify-indel-
regions.pl −−min-count 2 −−indel-window 5) and repetitive
and difficult to map regions (separately identified by repeat
masking the genome [http://www.repeatmasker.org/]) were
excluded (popoolation2 filter-sync-by-gtf.pl). The synchro-
nised file was used as input to determine pairwise FST
which was calculated in 10 kbp windows throughout the
genome (popoolation2 fst-sliding.pl --pool-size 50 --window-
size 10,000 --step-size 5000 --min-count 4 --min-coverage 50
--max-coverage 2%). Similarly, per base comparisons were
determined using a Fisher’s exact test (popoolation2
fisher-test.pl --min-count 4 --min-coverage 50 --max-
coverage 2% --suppress-noninformative).
Copy number variation between parental strains was
determined using cnv-seq [63]. Best read mapping hits
were determined per bam (samtools-1.3 view -F 4
bam | perl -lane ‘print “$F[2]\t$F[3]”‘> bam.hits),
before read counts for pairwise comparisons determined
in 10 kbp sliding windows using cnv-seq.pl. The R package
cnv (v 0.2–8) was used to determine pairwise
chromosome-wide normalised log2 ratios. Characterisation
of structural variation in the parental populations was
performed using the speedseq sv pipeline [64] to identify
putative duplications, deletions and inversions in each
population. This approach exploits all reads mapped using
BWA-MEM, including split and discordant read pairs,
which are subsequently scored using LUMPY and SVTyper.
Conservative filtering was applied to retain only homozy-
gous variants (1/1) with a minimum quality score of 100.
Population genetic modelling
Bespoke single-locus and multi-locus models were used
for population genetic inference from the data. Com-
mon to both methods, variants in the genome poten-
tially associated with resistance were identified. At each
locus in the genome, a nucleotide {A,C,G,T} was de-
fined as existing in the susceptible parental population
if it was observed at a frequency of at least 1% in that
population. Loci in the resistant parental population
were then identified for which exactly one nucleotide
that did not exist in the susceptible population was ob-
served at a frequency of at least 1%; without prejudice
as to its phenotypic effect, this was denoted the
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‘resistant’ allele at that locus, being associated with the
resistant parental population.
Single-locus model
A single-locus population genetic model was then used
to identify variants with frequencies that were inconsist-
ent with selective neutrality. The neutral expectation
was calculated using a Wright-Fisher evolutionary model
to simulate the progress of a variant allele, modelling the
probability distribution of the frequencies of homozy-
gous resistant (q1), heterozygous (qh), and homozygous
susceptible (q0) individuals throughout the course of the
experiment under the assumption of selective neutrality.
The Wright-Fisher model uses a simple multinomial
process for propagation; if the next generation of the
population contains N individuals, the probability of
obtaining n1, nh, and n0 individuals with each diploid
variant is given by:
P n1; nh; n0ð Þ ¼ N !n1!nh!n0! q
n1
1 q
nh
h q
n0
0 ð1Þ
At the stages in the experiment where the popula-
tion was comprised of eggs, we assumed N to be
large, such that the processes of crossing and back-
crossing could be described deterministically. Under
these circumstances the genotype frequencies follow-
ing a cross are given by:
q1′ ¼ q21 þ q1qh þ 0:25q2h
qh′ ¼ q1qh þ 2q1q0 þ 0:5q2h þ qhq0
q0′ ¼ q20 þ qhq0 þ 0:25q2h
ð2Þ
Where a prime denotes the frequency in the next gener-
ation. Similarly, the genotype frequencies following a
backcross with the homozygous susceptible population
are given by:
q01 ¼ 0
q0h ¼ q1 þ 0:5qh
q00 ¼ q0 þ 0:5qh
ð3Þ
Evaluating this process gives a probability distribution
for the frequency of the resistant allele at any given
point in the experiment, dependent upon the number of
resistant alleles in the initial resistant population. This
number of resistant alleles, which we denote nr, is un-
known; sequence data from the resistant parental popu-
lation were used to generate a prior distribution for this
value.
We first suppose that the frequency of the resistant
allele in the resistant parental population is equal to
some value, pr. Given that the initial experimental
population contains 50 resistant worms, with 100
alleles, collected from this larger population, the dis-
tribution of nr.
is then given by:
P nr ¼ jð Þ ¼ 100j
 
pjr 1−prð Þ100− j ð4Þ
We now suppose that sequencing the resistant paren-
tal population gave ar resistant alleles at the locus in
question out of a total read depth of Ar. The initial fre-
quency pr is unknown; however, using the data an esti-
mate can be made for this statistic, expressed as a
distribution of the allele frequency. Specifically, under
the assumption of a uniform prior, the underlying prob-
ability pr can be said to be distributed as a beta distribu-
tion with parameters ar and Ar - ar + 1. We therefore
obtain the following distribution for the statistic nr:
Pðnr ¼ jÞ ¼
Z
0
1 Ar!
ðar −1Þ!ðAr −arÞ! p
ar−1
r ð1−prÞAr−ar
100
j
 !
pjrð1−prÞ100− jdpr
ð5Þ
for any value of j between 0 and 100. Values of this
distribution were calculated using numerical integration.
This process generated the neutral expectation of the re-
sistant allele frequency conditional on the observation of
this frequency in the resistant population. If at the sam-
pling point t, a total of Nt worms were collected, the dis-
tribution of the number of worms nt with the resistant
allele at that point is given by:
P nt ¼ kð Þ ¼
X
j
P nt jnr ¼ jð ÞP nr ¼ jð Þ ð6Þ
for all 0 ≤ k ≤ Nt.
The extent to which observed allele frequencies were
consistent with the neutral model was calculated using a
likelihood model:
Lt ¼
XNt
k¼0
P nr ¼ kð Þ Atat
 
k=Ntð Þat 1− k=Ntð Þð ÞAt−at ð7Þ
where at time t, at resistant alleles from a read depth of
At were observed. A low likelihood Lt indicates deviation
from the neutral expectation; Bonferroni correction was
used to identify significance at the 95% level. Data from
each sample were analysed; four-fold non-neutral sites,
being loci for which a significant likelihood was
Doyle et al. BMC Genomics          (2019) 20:218 Page 15 of 19
calculated from all four samples collected throughout
each cross experiment, were identified.
Multi-locus model
A multi-locus model was developed to describe the
manner in which allele frequencies would be expected to
change over the course of the experiment; this model
exploits information about the location of variant loci
provided in the H. contortus reference genome, and the
genome-wide map of recombination rate in the worms
[21]; this map was inferred by characterising recombin-
ation breakpoints in F1 L3 progeny by whole genome
sequencing, from which recombination rates were deter-
mined by comparing genetic distances between SNPs
against their physical location in the genome. Where
fixed genetic differences occur between the parental
populations, the dynamics of adaptation in the resulting
cross are relatively straightforward [48, 50]; this has been
exploited to identify quantitative trait loci in yeast and
malaria cross populations [49, 65]. Here a heuristic
approach was used to identify fixed genetic differences
between the parental populations before modelling
evolution at these loci to identify the location of alleles
conveying drug resistance.
Three filters were used to identify putatively fixed differ-
ences between parental populations. Firstly, we identified
genomic sites for which the frequency of the resistant
allele was 95% or greater in the resistant parent, requiring
a read depth of at least 50x coverage for such sites to
achieve a good level of statistical certainty. Secondly, we
noted that, following the backcross performed at the start
of the experiment, no locus can be homozygous for the
resistant allele and as such, the resistant allele frequency
can be no greater than 50% in the population; by way of
reducing noise, we removed any locus with resistant al-
leles at a frequency of 60% or greater in the MHco3/
10.BC4.noIVM sequence data. Thirdly, we noted that at
homozygous separating sites in a population following a
cross, the allele frequency will change smoothly over time;
where there are N genomes in the population, the allele
frequency, considered as a function of chromosome pos-
ition, will change by 1/N wherever a crossover recombin-
ation event occurs within a genome. A diffusion model of
allele frequency change, described in a previous publica-
tion [49], was used to identify allele frequencies across the
genome that were consistent with this pattern. This ana-
lysis fits a posterior distribution to the allele frequencies
across the genome, also inferring the extent of noise in
the sequence data via a beta-binomial model intrinsic to
the fitting process. Conservatively, sites no more than
eight standard deviations from the mean of the posterior
frequencies were included in the analysis. These ap-
proaches resulted in data from a total of 1368 loci in the
MHco10(CAVR) dataset, and from 219 loci in the
MHco4(WRS) dataset, were retained; the full set of allele
frequencies are shown in Additional file 11: Figure S5.
Considering these data, we used an individual-based
Wright-Fisher simulation to model the outcome of the
experiment, taking into account the backcrossing, selection,
and bottlenecking according to the experimental design.
This approach accounted for the stochastic nature of allele
frequency changes due to the effect of repeated population
bottlenecking. We suppose that selection acts in favour of
the resistance allele at a given locus when worms are in a
sheep being treated with ivermectin, such that the fitness of
individuals that are homozygous for the resistant allele (w1),
heterozygous for the resistant allele (wh), or homozygous
for susceptible alleles (w0) are given by:
w1 ¼ 1þ s
wh ¼ 1þ hs
w0 ¼ 1
ð8Þ
where s is the selection coefficient (fitness advantage of
the homozygous resistant compared to homozygous sus-
ceptible) and h is the dominance coefficient (proportion
of fitness change conveyed by a single copy of the allele).
We assumed that all worms have equal fitness in the ab-
sence of the drug.
Our model is defined in terms of the manner in which
selection acts upon the population, by the location in
the genome of the selected allele, and the extent to
which that allele conveys a fitness advantage to worms
in the presence of drug treatment, this fitness advantage
being characterised in terms of s and h. The likelihood of
any given model was calculated using the beta-binomial
likelihood function obtained from the diffusion process
used above. Accounting for the stochasticity of the system,
a set of at least 250 simulations were generated for each
set of parameters, calculating the mean likelihood fit to
the data across the simulations. A bootstrapping process
was applied to quantify the uncertainty in this likelihood.
Parameters giving the maximum likelihood fit to the data
were identified.
Confidence intervals for the maximum likelihood loca-
tions of the selected allele were calculated. At the max-
imum likelihood position, we took the 250 simulations
giving the maximum mean likelihood, calculating the
mean of their likelihoods and the standard deviation of
these values. We defined a threshold likelihood as the
mean minus one standard deviation. For other allele
positions, we also identified the parameters giving the
maximum mean likelihood, constrained by allele pos-
ition; we calculated a test likelihood equal to the mean
plus one standard deviation of the replicate likelihoods
generated by these parameters. Confidence intervals
were then generated as the sites nearest the maximum
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likelihood position for which the test likelihood was
lower than the threshold likelihood. We believe this
gives a conservative estimate of the uncertainty in the
location of the selected allele, given the stochasticity in-
herent in the experiment.
In an extension to this model, a two-driver scenario
was considered, in which the resistant variant at each of
two loci was under selection; to allow the exploration of
model space in this case within reasonable computational
time the assumption was made of additive selection at
each locus. To distinguish this from the single-driver
model, a requirement was imposed that the selected
alleles be separated by at least 2 Mbp in the genome; this
distance reflects the extent to which the process of recom-
bination during the experiment allows the selective effects
of distinct alleles to be observed.
Additional files
Additional file 1: Figure S1. Characterisation of within-population
diversity. A. Within population nucleotide diversity per chromosome,
summarising genome-wide data presented in Fig. 2c. Colours represent
chromosomes as described in Fig. 2a. B. Linkage disequilibrium between
variants present in paired reads was estimated using LDx for each
parental population. Line represents expected LD decay over genetic
distance [60, 61]. (TIF 16681 kb)
Additional file 2: Figure S2. Distribution of “private” variant sites per
parental population. A. MHco3(ISE). B. MHco10(CAVR). C. MHco4(WRS).
Private sites were defined as having a frequency greater than 0.05 in the
population of interest, but less than 0.05 in the two additional populations.
(TIF 19122 kb)
Additional file 3: Figure S3. Copy number and structural variation in
the parental lines. A,B. MHco3(ISE), C,D. MHco10(CAVR), E,F. MHco4(WRS).
Data per circos plot (A,C,E) is orientated as follows; outer circle: CNV
variation between MHco3(ISE) and each resistant parent. No CNV comparison
was made in A; second circle: deletions; third circle: duplications; inner circle:
inversions. The data presented in A,C,E is summarised in the boxplots (feature
length distribution) and tables in B,D,F. (TIF 40104 kb)
Additional file 4: Figure S4. Summary of genome-wide change in FST
throughout the backcross and subsequent passage. Linear regression
between FST and the four sampling time points was performed for each
10 kbp window sampled across the genome for both MHco3/10 (A) and
MHco3/4 (B). The slope of the regression was plotted. Panel C shows the
correlation between the slopes (FST vs backcross progression) for MHco3/
10 (A) and MHco3/4 (B). The dashed line represents x = y. Colours represent
chromosomes as described in Fig. 2a. (PNG 140 kb)
Additional file 5: Figure S6. Location of significantly non-neutral loci
identified using the single-locus population genetic model. Corresponding
peaks in the location of significant sites can be seen in the MHco3/10 (A) and
MHco3/4 datasets (B). A total of 70.6% of significant sites in the MHco3/10
dataset, and 90.6% of significant sites in the MHco3/4 dataset, were found in
chromosome V. Data are binned in 1 Mbp windows spanning the genome.
Colours represent chromosomes as described in Fig. 2a. (TIF 13064 kb)
Additional file 6: Figure S7. Analysis of Tajima’s D variation in each
chromosome per cross. Comparison of Tajima’s D per chromosome
between MHco3(ISE) parent (blue), MHco10(CAVR) (panel column 1; red)
or MHco4(WRS) (panel column 3; red) and passages 3 (orange) and 4
(yellow) of the crosses. Tajima’s D was calculated using npstat in 100 kbp
windows spanning the genome. The variance in the mean value of
Tajima’s D among MHco3(ISE) and passages 3 and 4 – for which an
increase in variance would suggest introgression and evidence of
selection – was determined and is presented as smoothed line (red) in
panel columns 2 and 4. (TIF 23273 kb)
Additional file 7: Table S2. Candidate genes from literature proposed
to be associated with ivermectin resistance in Haemonchus contortus
and/or Caenorhabditis elegans. (DOCX 18 kb)
Additional file 8: Figure S9. Relative position and location of candidate
genes from the literature proposed to be associated with ivermectin
resistance in Haemonchus contortus and/or Caenorhabditis elegans. Gene
coordinates are presented in S2 Table. Colours represent chromosomes
as described in Fig. 2a. (TIF 10253 kb)
Additional file 9: Figure S10. Haplotype structure of chromosome V in
an example output from the model under neutral evolution. Segments of
genome from the resistant parent are shown in red, while segments of
genome from the susceptible parent are shown in blue. The repeated
backcross removes most of the resistant genotypes from the population.
(TIF 8743 kb)
Additional file 10: Figure S8. Contour maps of log likelihood scores
derived from the two locus driver model. A. MHco10(CAVR). B.
MHco4(WRS). The model was restricted to interactions between pairs of
loci at least 2 Mbp apart. (TIF 14861 kb)
Additional file 11: Figure S5. Fits between the model and the data for
each data sample. Blue dots show filtered allele frequencies for putative
segregating sites. The model fit is shown as gray lines; a distinct line is
shown for each of the 250 replicate simulations run for the parameters
generating the maximum likelihood fit. A. MHco3/10.BC4.noIVM. B.
MHco3/10.BC4.IVM. C. MHco3/10.BC4.IVM.P3. D. MHco3/10.BC4.IVM.P4. E.
MHco3/4.BC4.noIVM. F. MHco3/4.BC4.IVM. G. MHco3/4.BC4.IVM.P3. H.
MHco3/4.BC4.IVM.P4. (TIF 9801 kb)
Additional file 12: Table S1. Sample sequencing data archived at
European Nucleotide Archive repository under the study accession
PRJEB2353. (XLSX 12 kb)
Acknowledgements
We thank Pathogen Informatics and DNA Pipelines (WSI) for their support
and expertise, and Guillaume Sallé and the Parasite Genomics team at WSI
for constructive feedback on the manuscript. We are grateful to the Bioservices
Division, Moredun Research Institute, for expert care and assistance with animals.
Funding
Work at the Wellcome Sanger Institute was funded by Wellcome (grants
098051 and 206194) and by the Biotechnology and Biological Sciences
Research Council (BB/M003949). Work at the Moredun Research Institute was
funded by The Scottish Government’s Rural and Environment Science and
Analytical Services Division (RESAS) and at the University of Glasgow by
Wellcome Trust (grant 094751), the Scottish Government under the Scottish
Partnership for Animal Science Excellence and BBSRC (BB?M))3949). CJRI was
supported by a Sir Henry Dale Fellowship, jointly funded by Wellcome and
the Royal Society (grant 101239/Z/13/Z). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Availability of data and materials
The raw sequencing data generated during the current study are available in
the European Nucleotide Archive repository (http://www.ebi.ac.uk/ena/)
under the study accession number PRJEB2353 (Additional file 12: Table S1).
The reference genome assembly is available from ftp://ngs.sanger.ac.uk/
production/pathogens/Haemonchus_contortus. Code used in this project is
available from https://github.com/cjri/HCCross.
Authors’ contributions
SRD performed the genomic analyses, and wrote the manuscript. CJRI
performed the population modelling analyses, and wrote the manuscript. RL,
DB, ER, AR, ED and AAM, performed the genetic crosses and collected and
processed parasite material. AM, AT participated in genome curation. NH
coordinated samples and sequencing. ED and MB provided supervision and
guidance. NS, JAC and JSG participated in the experimental design and
study supervision, and helped write the manuscript. All authors read and
approved the final manuscript.
Doyle et al. BMC Genomics          (2019) 20:218 Page 17 of 19
Ethics approval and consent to participate
All experimental procedures described in this manuscript were examined
and approved by the Moredun Research Institute Experiments and Ethics
Committee and were conducted under approved British Home Office
licenses in accordance with the Animals (Scientific Procedures) Act of 1986.
The Home Office licence numbers were PPL 60/03899 and 60/4421, and the
experimental identifiers for these studies were E06/58, E06/75, E09/36 and
E14/30.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.
2Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, UK. 3Department of Applied Maths and Theoretical
Physics, Wilberforce Road, Cambridge CB3 0WA, UK. 4Institute of Biodiversity
Animal Health and Comparative Medicine, College of Medical, Veterinary and
Life Sciences, University of Glasgow, Garscube Campus, Glasgow, G61 1QH,
UK. 5Moredun Research Institute, Pentlands Science Park, Bush Loan, Penicuik
EH26 0PZ, UK. 6Department of Comparative Biology and Experimental
Medicine, Faculty of Veterinary Medicine, University of Calgary, Calgary,
Alberta, Canada. 7University of Edinburgh, Royal (Dick) School of Veterinary
Studies, Edinburgh EH25 9RG, UK. 8Present Address: Global Station for
Zoonosis Control, Global Institution for Collaborative Research and Education
(GI-CoRE), Hokkaido University, Sapporo, Japan. 9Present Address: Biological
and Environmental Sciences and Engineering (BESE) Division, King Abdullah
University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
Received: 1 November 2018 Accepted: 11 March 2019
References
1. Omura S, Crump A. The life and times of ivermectin - a success story. Nat
Rev Microbiol. 2004;2:984–9.
2. Kaplan RM, Vidyashankar AN. An inconvenient truth: global worming and
anthelmintic resistance. Vet Parasitol. 2012;186:70–8.
3. Rose H, Rinaldi L, Bosco A, Mavrot F, de Waal T, Skuce P, et al. Widespread
anthelmintic resistance in European farmed ruminants: a systematic review.
Vet Rec. 2015;176:546.
4. Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO,
Prichard RK. Phenotypic evidence of emerging ivermectin resistance in
Onchocerca volvulus. PLoS Negl Trop Dis. 2011;5:e998.
5. Doyle SR, Bourguinat C, Nana-Djeunga HC, Kengne-Ouafo JA, Pion SDS,
Bopda J, et al. Genome-wide analysis of ivermectin response by Onchocerca
volvulus reveals that genetic drift and soft selective sweeps contribute to
loss of drug sensitivity. PLoS Negl Trop Dis. 2017;11:e0005816.
6. Crellen T, Walker M, Lamberton PHL, Kabatereine NB, Tukahebwa EM,
Cotton JA, et al. Reduced Efficacy of Praziquantel Against Schistosoma
mansoni Is Associated With Multiple Rounds of Mass Drug Administration.
Clin Infect Dis. 2016;63:1151–9.
7. Geerts S, Gryseels B. Drug Resistance in Human Helminths: Current Situation
and Lessons from Livestock. Clin Microbiol Rev. 2000;13:207–22.
8. Yadav CL, Kumar R, Uppal RP, Verma SP. Multiple anthelmintic resistance in
Haemonchus contortus on a sheep farm in India. Vet Parasitol. 1995;60:355–60.
9. Jabbar A, Campbell AJD, Charles JA, Gasser RB. First report of anthelmintic
resistance in Haemonchus contortus in alpacas in Australia. Parasit Vectors.
2013;6:243.
10. Echevarria F, Trindade G. Anthelmintic resistance by Haemonchus contortus
to ivermectin in Brazil: a preliminary report. Vet Rec. 1989;124:147–8.
11. Van den Brom R, Moll L, Kappert C, Vellema P. Haemonchus contortus
resistance to monepantel in sheep. Vet Parasitol. 2015;209:278–80.
12. Howell SB, Burke JM, Miller JE, Terrill TH, Valencia E, Williams MJ, et al.
Prevalence of anthelmintic resistance on sheep and goat farms in the
southeastern United States. J Am Vet Med Assoc. 2008;233:1913–9.
13. Williamson SM, Storey B, Howell S, Harper KM, Kaplan RM, Wolstenholme AJ.
Candidate anthelmintic resistance-associated gene expression and
sequence polymorphisms in a triple-resistant field isolate of Haemonchus
contortus. Mol Biochem Parasitol. 2011;180:99–105.
14. van Wyk JA, Malan FS. Resistance of field strains of Haemonchus contortus
to ivermectin, closantel, rafoxanide and the benzimidazoles in South Africa.
Vet Rec. 1988;123:226–8.
15. Gilleard JS. Haemonchus contortus as a paradigm and model to study
anthelmintic drug resistance. Parasitology. 2013;140:1506–22.
16. Nisbet AJ, Meeusen EN, González JF, Piedrafita DM. Immunity to
Haemonchus contortus and Vaccine Development. In: Advances in
Parasitology; 2016. p. 353–96.
17. Geary TG. Haemonchus contortus: Applications in Drug Discovery. Adv
Parasitol. 2016;93:429–63.
18. Britton C, Roberts B, Marks ND. Functional Genomics Tools for Haemonchus
contortus and Lessons From Other Helminths. Adv Parasitol. 2016;93:599–623.
19. Laing R, Kikuchi T, Martinelli A, Tsai IJ, Beech RN, Redman E, et al. The
genome and transcriptome of Haemonchus contortus, a key model parasite
for drug and vaccine discovery. Genome Biol. 2013;14:R88.
20. Schwarz EM, Korhonen PK, Campbell BE, Young ND, Jex AR, Jabbar A, et al.
The genome and developmental transcriptome of the strongylid nematode
Haemonchus contortus. Genome Biol. 2013;14:R89.
21. Doyle SR, Laing R, Bartley DJ, Britton C, Chaudhry U, Gilleard JD, et al. A
genome resequencing-based genetic map reveals the recombination
landscape of an outbred parasitic nematode in the presence of polyploidy
and polyandry. Genome Biol Evol. 2018;10:396–409.
22. Kotze AC, Hunt PW, Skuce P, von Samson-Himmelstjerna G, Martin RJ, Sager
H, et al. Recent advances in candidate-gene and whole-genome
approaches to the discovery of anthelmintic resistance markers and the
description of drug/receptor interactions. Int J Parasitol Drugs Drug Resist.
2014;4:164–84.
23. Blackhall WJ, Pouliot J-F, Prichard RK, Beech RN. Haemonchus contortus:
Selection at a Glutamate-Gated Chloride Channel Gene in Ivermectin- and
Moxidectin-Selected Strains. Exp Parasitol. 1998;90:42–8.
24. Eng JKL, Blackhall WJ, Osei-Atweneboana MY, Bourguinat C, Galazzo D, Beech
RN, et al. Ivermectin selection on β-tubulin: Evidence in Onchocerca volvulus
and Haemonchus contortus. Mol Biochem Parasitol. 2006;150:229–35.
25. Luo X, Shi X, Yuan C, Ai M, Ge C, Hu M, et al. Genome-wide SNP analysis using
2b-RAD sequencing identifies the candidate genes putatively associated with
resistance to ivermectin in Haemonchus contortus. Parasit Vectors. 2017;10:31.
26. Blackhall WJ, Prichard RK, Beech RN. Selection at a γ-aminobutyric acid
receptor gene in Haemonchus contortus resistant to avermectins/
milbemycins. Mol Biochem Parasitol. 2003;131:137–45.
27. Urdaneta-Marquez L, Bae SH, Janukavicius P, Beech R, Dent J, Prichard R. A
dyf-7 haplotype causes sensory neuron defects and is associated with
macrocyclic lactone resistance worldwide in the nematode parasite
Haemonchus contortus. Int J Parasitol. 2014;44:1063–71.
28. Raza A, Kopp SR, Bagnall NH, Jabbar A, Kotze AC. Effects of in vitro exposure
to ivermectin and levamisole on the expression patterns of ABC
transporters in Haemonchus contortus larvae. Int J Parasitol Drugs Drug
Resist. 2016;6:103–15.
29. Lloberas M, Alvarez L, Entrocasso C, Virkel G, Ballent M, Mate L, et al.
Comparative tissue pharmacokinetics and efficacy of moxidectin, abamectin
and ivermectin in lambs infected with resistant nematodes: Impact of drug
treatments on parasite P-glycoprotein expression. Int J Parasitol Drugs Drug
Resist. 2013;3:20–7.
30. Laing R, Maitland K, Lecová L, Skuce PJ, Tait A, Devaney E. Analysis of putative
resistance gene loci in UK field populations of Haemonchus contortus after 6
years of macrocyclic lactone use. Int J Parasitol. 2016;46:621–30.
31. Rezansoff AM, Laing R, Gilleard JS. Evidence from two independent
backcross experiments supports genetic linkage of microsatellite Hcms8a20,
but not other candidate loci, to a major ivermectin resistance locus in
Haemonchus contortus. Int J Parasitol. 2016;46:653–61.
32. Prichard R. Genetic variability following selection of Haemonchus contortus
with anthelmintics. Trends Parasitol. 2001;17:445–53.
33. Beech RN, Skuce P, Bartley DJ, Martin RJ, Prichard RK, Gilleard JS.
Anthelmintic resistance: markers for resistance, or susceptibility?
Parasitology. 2011;138:160–74.
Doyle et al. BMC Genomics          (2019) 20:218 Page 18 of 19
34. Doyle SR, Cotton JA. Genome-wide Approaches to Investigate Anthelmintic
Resistance. Trends Parasitol. 2019. https://doi.org/10.1016/j.pt.2019.01.004.
35. Sargison ND, Redman E, Morrison AA, Bartley DJ, Jackson F, Gijzel HN, et al.
A method for single pair mating in an obligate parasitic nematode. Int J
Parasitol. 2018;48:159–65.
36. Le Jambre LF, Gill JH, Lenane IJ, Baker P. Inheritance of avermectin
resistance in Haemonchus contortus. Int J Parasitol. 2000;30:105–11.
37. Sangster NC, Redwin JM, Bjorn H. Inheritance of levamisole and
benzimidazole resistance in an isolate of Haemonchus contortus. Int J
Parasitol. 1998;28:503–10.
38. Hunt PW, Kotze AC, Knox MR, Anderson LJ, McNALLY J, Le Jambre LF. The
use of DNA markers to map anthelmintic resistance loci in an intraspecific
cross of Haemonchus contortus. Parasitology. 2009;137:705.
39. Redman E, Sargison N, Whitelaw F, Jackson F, Morrison A, Bartley DJ, et al.
Introgression of ivermectin resistance genes into a susceptible Haemonchus
contortus strain by multiple backcrossing. PLoS Pathog. 2012;8:e1002534.
40. Le Jambre LF, Royal WM. Meiotic abnormalities in backcross lines of hybrid
Haemonchus. Int J Parasitol. 1980;10:281–6.
41. Chevalier FD, Valentim CLL, LoVerde PT, Anderson TJC. Efficient linkage
mapping using exome capture and extreme QTL in schistosome parasites.
BMC Genomics. 2014;15:617.
42. Culleton R, Martinelli A, Hunt P, Carter R. Linkage group selection: rapid
gene discovery in malaria parasites. Genome Res. 2005;15:92–7.
43. Cheeseman IH, McDew-White M, Phyo AP, Sriprawat K, Nosten F, Anderson
TJC. Pooled sequencing and rare variant association tests for identifying the
determinants of emerging drug resistance in malaria parasites. Mol Biol
Evol. 2015;32:1080–90.
44. Choi Y-J, Bisset SA, Doyle SR, Hallsworth-Pepin K, Martin J, Grant WN, et al.
Genomic introgression mapping of field-derived multiple-anthelmintic
resistance in Teladorsagia circumcincta. PLoS Genet. 2017;13:e1006857.
45. Bourguinat C, Lee ACY, Lizundia R, Blagburn BL, Liotta JL, Kraus MS, et al.
Macrocyclic lactone resistance in Dirofilaria immitis: Failure of heartworm
preventives and investigation of genetic markers for resistance. Vet Parasitol.
2015;210:167–78.
46. Roos MH, Otsen M, Hoekstra R, Veenstra JG, Lenstra JA. Genetic analysis of
inbreeding of two strains of the parasitic nematode Haemonchus contortus.
Int J Parasitol. 2004;34:109–15.
47. Howe KL, Bolt BJ, Shafie M, Kersey P, Berriman M. WormBase ParaSite − a
comprehensive resource for helminth genomics. Mol Biochem Parasitol.
2017;215:2–10.
48. Illingworth CJR, Mustonen V. Quantifying selection in evolving populations
using time-resolved genetic data. J Stat Mech: Theory Exp. 2013;2013:P01004.
49. Abkallo HM, Martinelli A, Inoue M, Ramaprasad A, Xangsayarath P, Gitaka J,
et al. Rapid identification of genes controlling virulence and immunity in
malaria parasites. PLoS Pathog. 2017;13:e1006447.
50. Illingworth CJR, Parts L, Schiffels S, Liti G, Mustonen V. Quantifying selection
acting on a complex trait using allele frequency time series data. Mol Biol
Evol. 2012;29:1187–97.
51. Paten B, Novak AM, Eizenga JM, Garrison E. Genome graphs and the
evolution of genome inference. Genome Res. 2017;27:665–76.
52. Maciuca S, del Ojo EC, McVean G, Iqbal Z. A natural encoding of genetic
variation in a Burrows-Wheeler Transform to enable mapping and genome
inference; 2016. https://doi.org/10.1101/059170.
53. Sallé G, Doyle SR, Cortet J, Cabaret J, Berriman M, Holroyd N, et al. The
global diversity of a major parasitic nematode is shaped by human
intervention and climatic adaptation; 2018. https://doi.org/10.1101/450692.
54. Le Jambre LF, Gill JH, Lenane IJ, Lacey E. Characterisation of an avermectin
resistant strain of Australian Haemonchus contortus. Int J Parasitol. 1995;25:
691–8.
55. Denham DA. The Development of Ostertagia circumcincta in Lambs. J
Helminthol. 1969;43:299.
56. Kozarewa I, Ning Z, Quail MA, Sanders MJ, Berriman M, Turner DJ.
Amplification-free Illumina sequencing-library preparation facilitates
improved mapping and assembly of (G+C)-biased genomes. Nat Methods.
2009;6:291–5.
57. Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis
results for multiple tools and samples in a single report. Bioinformatics.
2016;32:3047–8.
58. Li H. Aligning sequence reads, clone sequences and assembly contigs with
BWA-MEM. arXiv http://arxiv.org/abs/1303.3997. 2013. http://arxiv.org/abs/
1303.3997. Accessed 25 Aug 2017.
59. Ferretti L, Ramos-Onsins SE, Pérez-Enciso M. Population genomics from pool
sequencing. Mol Ecol. 2013;22:5561–76.
60. Feder AF, Petrov DA, Bergland AO. LDx: estimation of linkage disequilibrium
from high-throughput pooled resequencing data. PLoS One. 2012;7:e48588.
61. Hill WG, Weir BS. Variances and covariances of squared linkage disequilibria
in finite populations. Theor Popul Biol. 1988;33:54–78.
62. Kofler R, Pandey RV, Schlötterer C. PoPoolation2: identifying differentiation
between populations using sequencing of pooled DNA samples (Pool-Seq).
Bioinformatics. 2011;27:3435–6.
63. Xie C, Tammi MT. CNV-seq, a new method to detect copy number variation
using high-throughput sequencing. BMC Bioinformatics. 2009;10:80.
64. Chiang C, Layer RM, Faust GG, Lindberg MR, Rose DB, Garrison EP, et al.
SpeedSeq: ultra-fast personal genome analysis and interpretation. Nat
Methods. 2015;12:966–8.
65. Parts L, Cubillos FA, Warringer J, Jain K, Salinas F, Bumpstead SJ, et al.
Revealing the genetic structure of a trait by sequencing a population under
selection. Genome Res. 2011;21:1131–8.
Doyle et al. BMC Genomics          (2019) 20:218 Page 19 of 19
